All Middle East & Africa articles – Page 7
-
NewsFirst detection of zoonotic Rickettsia species in dog ticks from Malawi reveals potential public health risk
An international research team has reported the first molecular detection of Rickettsia bacteria in ticks collected from domestic dogs in Malawi, addressing a significant knowledge gap in understanding tick-borne disease risks in southeastern Africa.
-
CareersSummer studentship: Taiwo uncovers native strains for mycotoxin control in stored nuts
Taiwo Boluwatife Omowunmi reports back on her AMI-sponsored summer studentship which assessed native microbial strains for mycotoxin biocontrol in stored nuts.
-
NewsHIV significantly affects sleep, with many living in a state akin to chronic jet lag
A new study describes how people living with HIV experience higher rates of sleep issues even when virally suppressed, which has been associated with a higher risk for heart disease, depression and cognitive decline.
-
NewsBreathing new life Into TB treatment with inhalable nanomedicine
Scientists are developing an inhalable nanosystem to transport TB medicines directly into the lungs, the very place where the bacterium that causes TB hides and thrives. The nanocarrier can hold all four standard TB drugs in a single formulation and release them precisely at the infection site.
-
NewsNew study reveals how immune cells help defend against candida infections
New research shows that eosinophils, immune cells usually linked to allergies, also play a protective role against Candida infections by using the CD48 receptor to recognize the fungus and release proteins that stop its growth.
-
NewsEurope backs first cervical cancer vaccination campaign in Angola
Angola’s first national vaccination campaign will immunise over 2 million girls aged 9–12 against cervical cancer. The national rollout began this week with coordinated delivery across schools, clinics, and communities in all 21 provinces.
-
NewsScientists develop novel gene therapy for hereditary hearing loss
Scientists have introduced an innovative gene therapy method to treat impairments in hearing and balance caused by inner ear dysfunction. The treatment holds promise for treating a wide range of mutations that cause hearing loss.
-
NewsMicrobes at Red Sea vents show how life and geology shape each other
A new study led by King Abdullah University of Science and Technology (KAUST; Saudi Arabia) Professor Alexandre Rosado has revealed an unusual microbial world in the Hatiba Mons hydrothermal vent fields of the central Red Sea, a site first discovered by one of his co-authors and colleagues, Assistant Professor Froukje ...
-
NewsNew hope for cats with eye infections: Study finds common cold sore cream safe and effective for feline use
A common human cold sore cream may soon help cats with painful eye infections: researchers found that 1% penciclovir cream (Fenlips®), when applied to cats’ eyes, was safe, well-tolerated, and maintained antiviral levels for over eight hours.
-
NewsScientist wins research grant to create mucin-on-a-chip for IBD research
Dr. Ilana Kolodkin-Gal of the Scojen Institute for Synthetic Biology has won a research grant from the BSF-NSF to investigate the role of invasive and pathogenic strains of intestinal bacteria in disrupting the integrity of the intestinal barrier.
-
NewsAfrican wildlife poop sheds light on what shapes the gut ecosystem
A study of elephants, giraffes and other wildlife in Namibia’s Etosha National Park underscores the ways in which the environment, biological sex, and anatomical distinctions can drive variation in the gut microbiomes across plant-eating species.
-
NewsIUCN members choose science and ethics in landmark vote on synthetic biology
The Wildlife Conservation Society (WCS) has hailed the adoption of Motion 87, supporting the responsible, evidence-based use of synthetic biology, at the IUCN World Conservation Congress in Abu Dhabi as a historic milestone for global conservation policy.
-
NewsResearchers probe how malaria harms unborn babies
UK-based Wellcome has awarded over €2 million to an international research effort to uncover how malaria can injure developing babies.
-
NewsFreshwater snails are an overlooked reservoir of AMR, study reveals
Freshwater snails across Africa and the UK carry bacteria containing a wide range of antimicrobial resistance (AMR) genes, including those predicted to confer resistance against last-resort antibiotics, according to a new study led by AMI members.
-
NewsMaldives is first country to achieve ‘triple elimination’ of mother-to-child transmission of HIV, syphilis and hepatitis B
The World Health Organization has validated the Maldives for eliminating mother-to-child transmission of hepatitis B, while maintaining its earlier validation for EMTCT of HIV and syphilis. This makes the Maldives the first country in the world to achieve ‘triple elimination’.
-
NewsScientist awarded $5 million to improve mental health and HIV care for adolescents in Uganda
The National Institutes of Health (NIH) has awarded Dr. Philip Kreniske $5,115,391 for a groundbreaking research project to improve mental health and antiretroviral treatment adherence among adolescents living with HIV in rural Uganda.
-
NewsNew one-hour, low-cost HPV test could transform cervical cancer screening in Africa and beyond
A team of researchers has developed a simple, affordable human papillomavirus (HPV) test that delivers results in less than an hour with no specialized laboratory required.
-
NewsGlobal Virus Network launches multi-country mpox diagnostic evaluation to close global preparedness gaps
The Global Virus Network has initiated one of the first coordinated, multi-country evaluations of rapid point-of-care mpox diagnostics, a critical step to prevent resurgence and ensure the world is better prepared for future epidemics.
-
NewsStudy models how human behavior, lockdowns and restrictions shaped COVID’s spread
Researchers employed computer modeling and large datasets to better understand how COVID-19 was transmitted in one community in South Africa during the course of the worldwide pandemic.
-
News NIH grant to UC Riverside supports research on dangerous emerging virus
Researchers have been awarded an NIH grant of about $3.4 million over five years to lead an international study focused on developing protective antibodies against Crimean-Congo hemorrhagic fever virus (CCHFV), a biosafety level 4 pathogen and a Category A bioterrorism agent.